Skip to main content
Premium Trial:

Request an Annual Quote

CORRECTION: RiboAmp Linear Amplification Method Is Distinct from Eberwine Protocol

Premium

The September 7 BioArray News story, “RNA Amplification Using T7 Method Gains Popularity as Commercial Version is Introduced,” included a factual error.

The story stated that the RiboAmp protocol, a linear amplification method being marketed by Arcturus, of Mountain View, Calif., is based on the same premise as the Eberwine protocol.

“The RiboAmp process is distinctly different from any of the published Eberwine protocols, and is based on a patent-pending linear amplification method developed at Arcturus,” said Rajiv Raja, a scientist at Arcturus.

“One of the key improvements is the use of exogenous primers and a proprietary enzyme mastermix, which maximizes the reliability of the reaction, minimizes reaction times, and provides greater uniformity in the length of the amplified aRNA product,” Raja said.

The RiboAmp kit, which Arcturus currently sells for $1,125, includes low-elution volume DNA and RNA purification columns and reagents, which are designed for obtaining large amounts of aRNA from minute sample sizes.

— MMJ

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.